Label Changes for:
Famvir (Famciclovir) Tablets
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2013
- Skin and subcutaneous tissue disorders: leukocytoclastic vasculitis
- Cardiac disorders: Palpitations